Allegro MicroSystems, Inc. (“Allegro” or the “Company”)
(Nasdaq:ALGM), a global leader in power and sensing
semiconductor solutions for motion control and energy efficient
systems, today announced financial results for its fourth quarter
and full year ended March 29, 2024.
“Continued strong momentum in e-Mobility drove
record fiscal year 2024 sales to more than $1 billion and record
non-GAAP earnings per share of $1.35. We also achieved a record
level of design wins of more than $1 billion. I would
like to thank the entire Allegro team for their contributions which
enabled us to achieve these significant milestones,” said Vineet
Nargolwala, President and CEO of Allegro. "During fiscal year 2024,
we strengthened our market-leading positions in magnetic sensing
and power solutions with the addition of highly differentiated TMR
technology to our portfolio and introduction of high voltage
isolated gate drivers to the market, enabling us to continue to
deliver innovative, high-value solutions to our customers. As we
look ahead into fiscal year 2025, our first quarter guide
comprehends working closely with customers to manage orders to
reduce inventory in the channel and return to normalized business
levels. We continue to expect a return to sequential growth in the
second quarter. Our design wins and continued momentum with
customers gives us confidence in the mid and longer-term growth
trajectory.”
Fourth Quarter and Full Fiscal Year 2024
Financial Highlights:
In thousands, except per share data |
|
Three-Month Period Ended |
|
|
Twelve-Month Period Ended |
|
|
|
March 29,2024 |
|
|
December 29,2023 |
|
|
March 31,2023* |
|
|
March 29,2024 |
|
|
March 31,2023* |
|
|
|
(Unaudited) |
|
|
(Unaudited) |
|
|
(Unaudited) |
|
|
(Unaudited) |
|
|
(Unaudited) |
|
Net Sales |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Automotive |
|
$ |
181,939 |
|
|
$ |
194,764 |
|
|
$ |
178,802 |
|
|
$ |
759,454 |
|
|
$ |
646,761 |
|
Industrial |
|
|
43,789 |
|
|
|
45,949 |
|
|
|
61,807 |
|
|
|
223,810 |
|
|
|
208,604 |
|
Other |
|
|
14,853 |
|
|
|
14,271 |
|
|
|
28,836 |
|
|
|
66,103 |
|
|
|
118,288 |
|
Total net sales |
|
$ |
240,581 |
|
|
$ |
254,984 |
|
|
$ |
269,445 |
|
|
$ |
1,049,367 |
|
|
$ |
973,653 |
|
GAAP Financial Measures |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross margin % |
|
|
51.2 |
% |
|
|
52.5 |
% |
|
|
56.8 |
% |
|
|
54.8 |
% |
|
|
56.1 |
% |
Operating margin % |
|
|
6.6 |
% |
|
|
14.4 |
% |
|
|
23.4 |
% |
|
|
18.7 |
% |
|
|
20.9 |
% |
Diluted EPS |
|
$ |
(0.04 |
) |
|
$ |
0.17 |
|
|
$ |
0.32 |
|
|
$ |
0.78 |
|
|
$ |
0.97 |
|
Non-GAAP Financial Measures |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross margin % |
|
|
53.8 |
% |
|
|
54.6 |
% |
|
|
57.8 |
% |
|
|
56.3 |
% |
|
|
56.8 |
% |
Operating margin % |
|
|
23.8 |
% |
|
|
27.2 |
% |
|
|
30.2 |
% |
|
|
28.5 |
% |
|
|
28.6 |
% |
Diluted EPS |
|
$ |
0.25 |
|
|
$ |
0.32 |
|
|
$ |
0.37 |
|
|
$ |
1.35 |
|
|
$ |
1.28 |
|
*During the preparation of the
third quarter fiscal year 2024 interim condensed consolidated
financial statements, the Company identified an immaterial error in
the classification of net sales by application with the table
above, whereby customer returns and sales allowances were
incorrectly classified by application between Automotive,
Industrial and Other in the prior periods presented above. There
was no impact to previously reported total net sales or net income
in any of the periods noted above.
Business Outlook
For the first quarter of fiscal year 2025 ending
June 28, 2024, the Company expects net sales to be in the range of
$160 million to $170 million. The Company also estimates the
following results on a non-GAAP basis:
- Gross Margin is expected to be between 49% and 50%,
- Operating Expenses are expected to be between $72 and $73
million, and
- Diluted Earnings per Share are expected to be in the range of
$0.01 to $0.03.
The Company also made a $50 million voluntary
payment on its term loan, which is expected to reduce annualized
interest expense by approximately $4 million dollars.
Allegro has not provided a reconciliation of its
first fiscal quarter outlook for non-GAAP Gross Margin, non-GAAP
Operating Expenses, and non-GAAP Diluted Earnings per Share because
estimates of all of the reconciling items cannot be provided
without unreasonable efforts. It is difficult to reasonably provide
a forward-looking estimate between such forward-looking non-GAAP
measures and the comparable forward-looking U.S. generally accepted
accounting principles (“GAAP”) measures. Certain factors that are
materially significant to Allegro’s ability to estimate these items
are out of its control and/or cannot be reasonably predicted.
Earnings Webcast
A webcast will be held on Thursday, May 9, 2024
at 8:30 a.m., Eastern Time. Vineet Nargolwala, President and Chief
Executive Officer, will discuss Allegro’s business and financial
results.
The webcast will be available on the Investor
Relations section of the Company’s website at
investors.allegromicro.com. A recording of the webcast will be
posted in the same location shortly after the call concludes and
will be available for at least 90 days.
About Allegro MicroSystems
Allegro MicroSystems is a leading global
designer, developer, fabless manufacturer and marketer of sensor
integrated circuits (“ICs”) and application-specific analog power
ICs enabling emerging technologies in the automotive and industrial
markets. Allegro’s diverse product portfolio provides efficient and
reliable solutions for the electrification of vehicles, automotive
ADAS safety features, automation for Industry 4.0 and power saving
technologies for data centers and clean energy applications.
Forward-Looking Statements
This press release contains forward-looking
statements within the meaning of the Private Securities Litigation
Reform Act of 1995. We intend such forward-looking statements to be
covered by the safe harbor provisions for forward-looking
statements contained in Section 27A of the Securities Act of 1933,
as amended, and Section 21E of the Securities Exchange Act of 1934,
as amended. All statements, other than statements of historical
facts, contained in this press release including statements
regarding our future results of operations and financial position,
business strategy, prospective products and the plans and
objectives of management for future operations, including, among
others, statements regarding the liquidity, growth and
profitability strategies and factors affecting our business, are
forward-looking statements. These statements involve known and
unknown risks, uncertainties and other important factors that may
cause our actual results, performance or achievements to be
materially different from any future results, performance or
achievements expressed or implied by the forward-looking
statements.
Without limiting the foregoing, in some cases,
you can identify forward-looking statements by terms such as “aim,”
“may,” “will,” “should,” “expect,” “exploring,” “plan,”
“anticipate,” “could,” “intend,” “target,” “project,” “would,”
“contemplate,” “believe,” “estimate,” “predict,” “potential,”
“seek,” or “continue” or the negative of these terms or other
similar expressions, although not all forward-looking statements
contain these words. No forward-looking statement is a guarantee of
future results, performance or achievements, and one should avoid
placing undue reliance on such statements.
Forward-looking statements are based on our
management’s current expectations, beliefs and assumptions and on
information currently available to us. Such beliefs and assumptions
may or may not prove to be correct. Additionally, such
forward-looking statements are subject to a number of known and
unknown risks, uncertainties and assumptions, and actual results
may differ materially from those expressed or implied in the
forward-looking statements due to various factors, including, but
not limited to, those identified in Part II, Item 7. “Management’s
Discussion and Analysis of Financial Condition and Results of
Operations,” and Part I, Item 1A. “Risk Factors” in our Annual
Report on Form 10-K for the year ended March 31, 2023, as updated
in Part II, Item 1A “Risk Factors” of our Quarterly Report on Form
10-Q for the quarterly period ended December 29, 2023, filed with
the Securities and Exchange (“SEC”) on February 6, 2024. These
risks and uncertainties include, but are not limited to: downturns
or volatility in general economic conditions; our ability to
compete effectively, expand our market share and increase our net
sales and profitability; our reliance on a limited number of
third-party semiconductor wafer fabrication facilities and
suppliers of other materials; our failure to adjust purchase
commitments and inventory management based on changing market
conditions or customer demand; shifts in our product mix or
customer mix, which could negatively impact our gross margin; the
risk that the expected benefits of acquisitions may not be realized
or that integration of acquired businesses may not continue as
rapidly as we anticipate; the cyclical nature of the analog
semiconductor industry; any downturn or disruption in the
automotive market; our ability to compensate for decreases in
average selling prices of our products and increases in input
costs; our ability to manage any sustained yield problems or other
delays at our third-party wafer fabrication facilities or in the
final assembly and test of our products; our ability to accurately
predict our quarterly net sales and operating results; our ability
to adjust our supply chain volume to account for changing market
conditions and customer demand; our dependence on manufacturing
operations in the Philippines; our reliance on distributors to
generate sales; the effects of COVID-19 on our supply chain and
customer demand; our ability to develop new product features or new
products in a timely and cost-effective manner; our ability to
manage growth; any slowdown in the growth of our end markets; the
loss of one or more significant customers; our ability to meet
customers’ quality requirements; uncertainties related to the
design win process and our ability to recover design and
development expenses and to generate timely or sufficient net sales
or margins; changes in government trade policies, including the
imposition of export restrictions and tariffs; our exposures to
warranty claims, product liability claims and product recalls; our
dependence on international customers and operations; the
availability of rebates, tax credits and other financial incentives
on end-user demands for certain products; risks, liabilities, costs
and obligations related to governmental regulation and other legal
obligations, including export control, privacy, data protection,
information security, consumer protection, environmental and
occupational health and safety, anti-corruption and anti-bribery,
and trade controls; the volatility of currency exchange rates; our
ability to raise capital to support our growth strategy; our
indebtedness may limit our flexibility to operate our business; our
ability to effectively manage our growth and to retain key and
highly skilled personnel; our ability to protect our proprietary
technology and inventions through patents or trade secrets; our
ability to commercialize our products without infringing
third-party intellectual property rights; disruptions or breaches
of our information technology systems or those of our third-party
service providers; our principal stockholders have substantial
control over us; the inapplicability of the “corporate opportunity”
doctrine to any director or stockholder who is not employed by us;
anti-takeover provisions in our organizational documents and under
the General Corporation Law of the State of Delaware; our inability
to design, implement or maintain effective internal control over
financial reporting; changes in tax rates or the adoption of new
tax legislation; the negative impacts of sustained inflation on our
business; disruptions in the banking and financial sector that
limit our or our partners’ ability to access capital and
borrowings; the physical, transition and litigation risks presented
by climate change; and other events beyond our control. Moreover,
we operate in an evolving environment. New risk factors and
uncertainties may emerge from time to time, and it is not possible
for management to predict all risk factors and uncertainties.
You should read this press release and the
documents that we reference completely and with the understanding
that our actual future results may be materially different from
what we expect. We qualify all of our forward-looking statements by
these cautionary statements. All forward-looking statements speak
only as of the date of this press release, and except as required
by applicable law, we do not plan to publicly update or revise any
forward-looking statements, whether as a result of any new
information, future events, changed circumstances or otherwise.
This press release includes certain non-GAAP
financial measures as defined by the SEC rules. These non-GAAP
financial measures are provided in addition to, and not as a
substitute for or superior to measures of, financial performance
prepared in accordance with GAAP. There are a number of limitations
related to the use of these non-GAAP financial measures versus
their nearest GAAP equivalents. For example, other companies may
calculate non-GAAP financial measures differently or may use other
measures to evaluate their performance, all of which could reduce
the usefulness of the presented non-GAAP financial measures as
tools for comparison.
This press release may not be reproduced,
forwarded to any person or published, in whole or in part.
ALLEGRO MICROSYSTEMS, INC.
CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS
(in thousands, except share and per share amounts)
(Unaudited)
|
|
Three-Month Period Ended |
|
|
Twelve-Month Period Ended |
|
|
|
March 29,2024 |
|
|
March 31,2023 |
|
|
March 29,2024 |
|
|
March 31,2023 |
|
Net sales |
|
$ |
240,581 |
|
|
$ |
269,445 |
|
|
$ |
1,049,367 |
|
|
$ |
973,653 |
|
Cost of goods sold |
|
|
117,333 |
|
|
|
116,356 |
|
|
|
474,838 |
|
|
|
427,574 |
|
Gross profit |
|
|
123,248 |
|
|
|
153,089 |
|
|
|
574,529 |
|
|
|
546,079 |
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
Research and development |
|
|
45,839 |
|
|
|
41,833 |
|
|
|
176,638 |
|
|
|
150,850 |
|
Selling, general and administrative |
|
|
48,294 |
|
|
|
48,152 |
|
|
|
188,429 |
|
|
|
191,922 |
|
Impairment of long-lived assets |
|
|
13,218 |
|
|
|
— |
|
|
|
13,218 |
|
|
|
— |
|
Total operating expenses |
|
|
107,351 |
|
|
|
89,985 |
|
|
|
378,285 |
|
|
|
342,772 |
|
Operating income |
|
|
15,897 |
|
|
|
63,104 |
|
|
|
196,244 |
|
|
|
203,307 |
|
Interest and other income (expense) |
|
|
1,354 |
|
|
|
4,817 |
|
|
|
(1,447 |
) |
|
|
8,039 |
|
Income before income taxes |
|
|
17,251 |
|
|
|
67,921 |
|
|
|
194,797 |
|
|
|
211,346 |
|
Income tax provision |
|
|
24,325 |
|
|
|
5,909 |
|
|
|
41,909 |
|
|
|
23,852 |
|
Net (loss) income |
|
|
(7,074 |
) |
|
|
62,012 |
|
|
|
152,888 |
|
|
|
187,494 |
|
Net income attributable to non-controlling interests |
|
|
41 |
|
|
|
35 |
|
|
|
191 |
|
|
|
137 |
|
Net (loss) income attributable to Allegro MicroSystems, Inc. |
|
$ |
(7,115 |
) |
|
$ |
61,977 |
|
|
$ |
152,697 |
|
|
$ |
187,357 |
|
Net (loss) income per common share attributable to Allegro
MicroSystems, Inc.: |
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
$ |
(0.04 |
) |
|
$ |
0.32 |
|
|
$ |
0.79 |
|
|
$ |
0.98 |
|
Diluted |
|
$ |
(0.04 |
) |
|
$ |
0.32 |
|
|
$ |
0.78 |
|
|
$ |
0.97 |
|
Weighted average shares outstanding: |
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
|
193,139,519 |
|
|
|
191,519,850 |
|
|
|
192,573,169 |
|
|
|
191,197,452 |
|
Diluted |
|
|
194,487,307 |
|
|
|
194,993,241 |
|
|
|
194,674,352 |
|
|
|
193,688,102 |
|
Supplemental Schedule of Total Net
Sales
The following table summarizes total net sales
by market within the Company’s unaudited consolidated statements of
operations:
|
|
Three-Month Period Ended |
|
|
Change |
|
|
Twelve-Month Period Ended |
|
|
Change |
|
|
|
March 29,2024 |
|
|
March 31,2023 |
|
|
Amount |
|
|
% |
|
|
March 29,2024 |
|
|
March 31,2023 |
|
|
Amount |
|
|
% |
|
|
|
(Dollars in thousands) |
|
|
(Dollars in thousands) |
|
Automotive |
|
$ |
181,939 |
|
|
$ |
178,802 |
|
|
$ |
3,137 |
|
|
|
2 |
% |
|
$ |
759,454 |
|
|
$ |
646,761 |
|
|
$ |
112,693 |
|
|
|
17 |
% |
Industrial |
|
|
43,789 |
|
|
|
61,807 |
|
|
|
(18,018 |
) |
|
|
(29 |
)% |
|
|
223,810 |
|
|
|
208,604 |
|
|
|
15,206 |
|
|
|
7 |
% |
Other |
|
|
14,853 |
|
|
|
28,836 |
|
|
|
(13,983 |
) |
|
|
(48 |
)% |
|
|
66,103 |
|
|
|
118,288 |
|
|
|
(52,185 |
) |
|
|
(44 |
)% |
Total net sales |
|
$ |
240,581 |
|
|
$ |
269,445 |
|
|
$ |
(28,864 |
) |
|
|
(11 |
)% |
|
$ |
1,049,367 |
|
|
$ |
973,653 |
|
|
$ |
75,714 |
|
|
|
8 |
% |
|
ALLEGRO MICROSYSTEMS, INC. CONDENSED
CONSOLIDATED BALANCE SHEETS (in thousands, except
share and per share amounts) |
|
|
|
March 29, |
|
|
March 31, |
|
|
|
2024 (Unaudited) |
|
|
2023 |
|
Assets |
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
212,143 |
|
|
$ |
351,576 |
|
Restricted cash |
|
|
10,018 |
|
|
|
7,129 |
|
Trade accounts receivable, net |
|
|
118,508 |
|
|
|
111,290 |
|
Trade and other accounts receivable due from related party |
|
|
207 |
|
|
|
13,494 |
|
Inventories |
|
|
162,302 |
|
|
|
151,301 |
|
Prepaid expenses and other current assets |
|
|
65,285 |
|
|
|
27,289 |
|
Current portion of related party note receivable |
|
|
3,750 |
|
|
|
3,750 |
|
Total current assets |
|
|
572,213 |
|
|
|
665,829 |
|
Property, plant and equipment, net |
|
|
321,175 |
|
|
|
263,099 |
|
Deferred income tax assets |
|
|
54,496 |
|
|
|
50,359 |
|
Goodwill |
|
|
202,425 |
|
|
|
27,691 |
|
Intangible assets, net |
|
|
276,854 |
|
|
|
52,378 |
|
Related party note receivable, less current portion |
|
|
4,688 |
|
|
|
8,438 |
|
Equity investment in related party |
|
|
26,727 |
|
|
|
27,265 |
|
Other assets |
|
|
72,025 |
|
|
|
86,096 |
|
Total assets |
|
$ |
1,530,603 |
|
|
$ |
1,181,155 |
|
Liabilities, Non-Controlling Interests and Stockholders'
Equity |
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
Trade accounts payable |
|
$ |
35,964 |
|
|
$ |
56,256 |
|
Amount due to related party |
|
|
1,626 |
|
|
|
9,682 |
|
Accrued expenses and other current liabilities |
|
|
76,389 |
|
|
|
99,387 |
|
Current portion of long-term debt |
|
|
3,929 |
|
|
|
— |
|
Total current liabilities |
|
|
117,908 |
|
|
|
165,325 |
|
Long-term debt |
|
|
249,611 |
|
|
|
25,000 |
|
Other long-term liabilities |
|
|
31,368 |
|
|
|
24,015 |
|
Total liabilities |
|
|
398,887 |
|
|
|
214,340 |
|
Commitments and contingencies |
|
|
|
|
|
|
Stockholders' Equity: |
|
|
|
|
|
|
Preferred stock |
|
|
— |
|
|
|
— |
|
Common stock |
|
|
1,932 |
|
|
|
1,918 |
|
Additional paid-in capital |
|
|
694,332 |
|
|
|
674,179 |
|
Retained earnings |
|
|
463,012 |
|
|
|
310,315 |
|
Accumulated other comprehensive loss |
|
|
(28,841 |
) |
|
|
(20,784 |
) |
Equity attributable to Allegro MicroSystems, Inc. |
|
|
1,130,435 |
|
|
|
965,628 |
|
Non-controlling interests |
|
|
1,281 |
|
|
|
1,187 |
|
Total stockholders' equity |
|
|
1,131,716 |
|
|
|
966,815 |
|
Total liabilities, non-controlling interests and stockholders'
equity |
|
$ |
1,530,603 |
|
|
$ |
1,181,155 |
|
|
|
ALLEGRO MICROSYSTEMS, INC. CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOWS (in
thousands) (Unaudited) |
|
|
|
|
|
Three Months Ended |
|
|
Twelve Months Ended |
|
|
|
March 29,2024 |
|
|
March 31,2023 |
|
|
March 29,2024 |
|
|
March 31,2023 |
|
Cash flows from operating activities: |
|
|
|
|
|
|
|
|
|
|
|
|
Net (loss) income |
|
$ |
(7,074 |
) |
|
$ |
62,012 |
|
|
$ |
152,888 |
|
|
$ |
187,494 |
|
Adjustments to reconcile net income to net cash provided by
operating activities: |
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
|
21,834 |
|
|
|
14,103 |
|
|
|
71,382 |
|
|
|
50,808 |
|
Amortization of deferred financing costs |
|
|
235 |
|
|
|
25 |
|
|
|
527 |
|
|
|
99 |
|
Deferred income taxes |
|
|
9,640 |
|
|
|
(11,729 |
) |
|
|
(18,613 |
) |
|
|
(40,116 |
) |
Stock-based compensation |
|
|
9,618 |
|
|
|
10,556 |
|
|
|
42,457 |
|
|
|
61,798 |
|
Loss (gain) on disposal of assets |
|
|
52 |
|
|
|
(2 |
) |
|
|
70 |
|
|
|
285 |
|
Change in fair value of contingent consideration |
|
|
— |
|
|
|
(100 |
) |
|
|
— |
|
|
|
(2,800 |
) |
Impairment of long-lived assets |
|
|
13,218 |
|
|
|
— |
|
|
|
13,218 |
|
|
|
— |
|
Provisions for inventory and expected credit losses |
|
|
435 |
|
|
|
(3,182 |
) |
|
|
10,286 |
|
|
|
(1,438 |
) |
Change in fair value of marketable securities |
|
|
— |
|
|
|
(7,476 |
) |
|
|
3,579 |
|
|
|
(7,471 |
) |
Changes in operating assets and liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
Trade accounts receivable |
|
|
(5,400 |
) |
|
|
(6,590 |
) |
|
|
(7,964 |
) |
|
|
(12,484 |
) |
Accounts receivable - other |
|
|
(573 |
) |
|
|
226 |
|
|
|
(1,035 |
) |
|
|
2,226 |
|
Inventories |
|
|
4,061 |
|
|
|
(36,014 |
) |
|
|
(15,848 |
) |
|
|
(75,150 |
) |
Prepaid expenses and other assets |
|
|
(27,608 |
) |
|
|
(5,502 |
) |
|
|
(40,231 |
) |
|
|
(23,263 |
) |
Trade accounts payable |
|
|
(3,049 |
) |
|
|
(7,595 |
) |
|
|
(12,653 |
) |
|
|
11,958 |
|
Due to (from) related party |
|
|
(1,586 |
) |
|
|
21,599 |
|
|
|
5,231 |
|
|
|
18,326 |
|
Accrued expenses and other current and long-term liabilities |
|
|
(1,039 |
) |
|
|
17,217 |
|
|
|
(21,579 |
) |
|
|
22,934 |
|
Net cash provided by operating activities |
|
|
12,764 |
|
|
|
47,548 |
|
|
|
181,715 |
|
|
|
193,206 |
|
Cash flows from investing activities: |
|
|
|
|
|
|
|
|
|
|
|
|
Purchases of property, plant and equipment |
|
|
(14,272 |
) |
|
|
(30,212 |
) |
|
|
(124,772 |
) |
|
|
(79,775 |
) |
Acquisition of business, net of cash acquired |
|
|
— |
|
|
|
(193 |
) |
|
|
(408,119 |
) |
|
|
(19,921 |
) |
Sales in marketable securities |
|
|
— |
|
|
|
— |
|
|
|
16,175 |
|
|
|
— |
|
Net cash used in investing activities |
|
|
(14,272 |
) |
|
|
(30,405 |
) |
|
|
(516,716 |
) |
|
|
(99,696 |
) |
Cash flows from financing activities: |
|
|
|
|
|
|
|
|
|
|
|
|
Loans made to related party |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(7,500 |
) |
Borrowings of 2023 term loan facility, net of deferred financing
costs |
|
|
— |
|
|
|
— |
|
|
|
245,452 |
|
|
|
— |
|
Repayment of 2020 term loan facility |
|
|
— |
|
|
|
— |
|
|
|
(25,000 |
) |
|
|
— |
|
Repayment of 2023 term loan facility |
|
|
(625 |
) |
|
|
— |
|
|
|
(625 |
) |
|
|
— |
|
Repayment of other debt |
|
|
(99 |
) |
|
|
— |
|
|
|
(842 |
) |
|
|
— |
|
Finance lease payments |
|
|
(142 |
) |
|
|
— |
|
|
|
(142 |
) |
|
|
— |
|
Receipts on related party note receivable |
|
|
937 |
|
|
|
937 |
|
|
|
3,750 |
|
|
|
2,812 |
|
Payments for taxes related to net share settlement of equity
awards |
|
|
(1,077 |
) |
|
|
(5,419 |
) |
|
|
(25,900 |
) |
|
|
(18,061 |
) |
Proceeds from issuance of common stock under equity award and
employee stock purchase plan |
|
|
1,736 |
|
|
|
1,220 |
|
|
|
3,635 |
|
|
|
2,793 |
|
Dividends paid to non-controlling interest |
|
|
— |
|
|
|
(42 |
) |
|
|
— |
|
|
|
(42 |
) |
Payment of debt issuance costs |
|
|
— |
|
|
|
— |
|
|
|
(1,450 |
) |
|
|
— |
|
Net cash provided by (used in) financing activities |
|
|
730 |
|
|
|
(3,304 |
) |
|
|
198,878 |
|
|
|
(19,998 |
) |
Effect of exchange rate changes on cash and cash equivalents and
restricted cash |
|
|
(796 |
) |
|
|
738 |
|
|
|
(421 |
) |
|
|
(4,606 |
) |
Net (decrease) increase in cash and cash equivalents and restricted
cash |
|
|
(1,574 |
) |
|
|
14,577 |
|
|
|
(136,544 |
) |
|
|
68,906 |
|
Cash and cash equivalents and restricted cash at beginning of
period |
|
|
223,735 |
|
|
|
344,128 |
|
|
|
358,705 |
|
|
|
289,799 |
|
Cash and cash equivalents and restricted cash at end of
period: |
|
$ |
222,161 |
|
|
$ |
358,705 |
|
|
$ |
222,161 |
|
|
$ |
358,705 |
|
Non-GAAP Financial Measures
In addition to the measures presented in our
consolidated financial statements, we regularly review other
measures, defined as non-GAAP financial measures by the SEC, to
evaluate our business, measure our performance, identify trends,
prepare financial forecasts and make strategic decisions. The key
measures we consider are non-GAAP Gross Profit, non-GAAP Gross
Margin, non-GAAP Operating Expenses, non-GAAP Operating Income,
non-GAAP Operating Margin, EBITDA, Adjusted EBITDA, Adjusted EBITDA
margin, non-GAAP Profit before Tax, non-GAAP Income Tax Provision,
non-GAAP Net Income, non-GAAP Basic and Diluted Earnings per Share,
and non-GAAP Free Cash Flow (collectively, the “Non-GAAP Financial
Measures”). These Non-GAAP Financial Measures provide supplemental
information regarding our operating performance on a non-GAAP basis
that excludes certain gains, losses and charges of a non-cash
nature or that occur relatively infrequently and/or that management
considers to be unrelated to our core operations, and in the case
of non-GAAP Income Tax Provision, management believes that this
non-GAAP measure of income taxes provides it with the ability to
evaluate the non-GAAP Income Tax Provision across different
reporting periods on a consistent basis, independent of special
items and discrete items, which may vary in size and frequency.
These Non-GAAP Financial Measures are used by both management and
our board of directors, together with the comparable GAAP
information, in evaluating our current performance and planning our
future business activities.
The Non-GAAP Financial Measures are supplemental
measures of our performance that are neither required by, nor
presented in accordance with, GAAP. These Non-GAAP Financial
Measures should not be considered as substitutes for GAAP financial
measures such as gross profit, gross margin, net income or any
other performance measures derived in accordance with GAAP. Also,
in the future we may incur expenses or charges such as those being
adjusted in the calculation of these Non-GAAP Financial Measures.
Our presentation of these Non-GAAP Financial Measures should not be
construed as an inference that future results will be unaffected by
unusual or nonrecurring items. These Non-GAAP Financial Measures
exclude costs related to acquisition and related integration
expenses, amortization of acquired intangible assets, stock-based
compensation, restructuring actions, related party activities and
other non-operational costs.
Non-GAAP Income Tax
Provision
In calculating non-GAAP Income Tax Provision, we
have added back the following to GAAP Income Tax Provision:
- Tax effect of adjustments to GAAP results—Represents the
estimated income tax effect of the adjustments to non-GAAP Profit
before Tax described below and elimination of discrete tax
adjustments.
Reconciliation of Non-GAAP Gross Profit |
|
|
Three-Month Period Ended |
|
|
Twelve-Month Period Ended |
|
|
|
March 29,2024 |
|
|
December 29,2023 |
|
|
March 31,2023 |
|
|
March 29,2024 |
|
|
March 31,2023 |
|
|
|
(Dollars in thousands) |
|
|
(Dollars in thousands) |
|
GAAP Gross Profit |
|
$ |
123,248 |
|
|
$ |
133,828 |
|
|
$ |
153,089 |
|
|
$ |
574,529 |
|
|
$ |
546,079 |
|
Non-GAAP adjustments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Transaction-related costs |
|
|
566 |
|
|
|
523 |
|
|
|
— |
|
|
|
1,089 |
|
|
|
— |
|
Purchased intangible amortization |
|
|
4,959 |
|
|
|
3,648 |
|
|
|
627 |
|
|
|
9,282 |
|
|
|
1,867 |
|
Restructuring costs |
|
|
1 |
|
|
|
166 |
|
|
|
— |
|
|
|
167 |
|
|
|
— |
|
Stock-based compensation |
|
|
734 |
|
|
|
1,073 |
|
|
|
1,978 |
|
|
|
5,359 |
|
|
|
5,090 |
|
Total Non-GAAP Adjustments |
|
$ |
6,260 |
|
|
$ |
5,410 |
|
|
$ |
2,605 |
|
|
$ |
15,897 |
|
|
$ |
6,957 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-GAAP Gross Profit |
|
$ |
129,508 |
|
|
$ |
139,238 |
|
|
$ |
155,694 |
|
|
$ |
590,426 |
|
|
$ |
553,036 |
|
Non-GAAP Gross Margin (% of net sales) |
|
|
53.8 |
% |
|
|
54.6 |
% |
|
|
57.8 |
% |
|
|
56.3 |
% |
|
|
56.8 |
% |
Reconciliation of Non-GAAP Operating Expenses |
|
|
Three-Month Period Ended |
|
|
Twelve-Month Period Ended |
|
|
|
March 29,2024 |
|
|
December 29,2023 |
|
|
March 31,2023 |
|
|
March 29,2024 |
|
|
March 31,2023 |
|
|
|
(Dollars in thousands) |
|
|
(Dollars in thousands) |
|
GAAP Operating Expenses |
|
$ |
107,351 |
|
|
$ |
97,142 |
|
|
$ |
89,985 |
|
|
$ |
378,285 |
|
|
$ |
342,772 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research and Development Expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP Research and Development Expenses |
|
|
45,839 |
|
|
|
44,396 |
|
|
|
41,833 |
|
|
|
176,638 |
|
|
|
150,850 |
|
Non-GAAP adjustments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Transaction-related costs |
|
|
929 |
|
|
|
343 |
|
|
|
— |
|
|
|
1,281 |
|
|
|
404 |
|
Restructuring costs |
|
|
621 |
|
|
|
908 |
|
|
|
72 |
|
|
|
1,529 |
|
|
|
72 |
|
Stock-based compensation |
|
|
3,554 |
|
|
|
3,870 |
|
|
|
3,483 |
|
|
|
13,894 |
|
|
|
9,496 |
|
Non-GAAP Research and Development Expenses |
|
|
40,735 |
|
|
|
39,275 |
|
|
|
38,278 |
|
|
|
159,934 |
|
|
|
140,878 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling, General and Administrative Expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP Selling, General and Administrative Expenses |
|
|
48,294 |
|
|
|
52,746 |
|
|
|
48,252 |
|
|
|
188,429 |
|
|
|
194,722 |
|
Non-GAAP adjustments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Transaction-related costs |
|
|
5,649 |
|
|
|
9,543 |
|
|
|
644 |
|
|
|
20,068 |
|
|
|
2,339 |
|
Purchased intangible amortization |
|
|
542 |
|
|
|
495 |
|
|
|
22 |
|
|
|
1,752 |
|
|
|
90 |
|
Restructuring costs |
|
|
1,819 |
|
|
|
5,795 |
|
|
|
492 |
|
|
|
7,614 |
|
|
|
5,155 |
|
Stock-based compensation |
|
|
5,330 |
|
|
|
5,977 |
|
|
|
5,095 |
|
|
|
23,204 |
|
|
|
47,212 |
|
Other costs |
|
|
3,514 |
|
|
|
283 |
|
|
|
5,944 |
|
|
|
3,897 |
|
|
|
5,944 |
|
Non-GAAP Selling, General and Administrative Expenses |
|
|
31,440 |
|
|
|
30,653 |
|
|
|
36,055 |
|
|
|
131,894 |
|
|
|
133,982 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Impairment of long-lived assets |
|
|
13,218 |
|
|
|
— |
|
|
|
— |
|
|
|
13,218 |
|
|
|
— |
|
Change in fair value of contingent consideration |
|
|
— |
|
|
|
— |
|
|
|
(100 |
) |
|
|
— |
|
|
|
(2,800 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Non-GAAP Adjustments |
|
|
35,176 |
|
|
|
27,214 |
|
|
|
15,652 |
|
|
|
86,457 |
|
|
|
67,912 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-GAAP Operating Expenses |
|
$ |
72,175 |
|
|
$ |
69,928 |
|
|
$ |
74,333 |
|
|
$ |
291,828 |
|
|
$ |
274,860 |
|
Reconciliation of Non-GAAP Operating Income |
|
|
Three-Month Period Ended |
|
|
Twelve-Month Period Ended |
|
|
|
March 29,2024 |
|
|
December 29,2023 |
|
|
March 31,2023 |
|
|
March 29,2024 |
|
|
March 31,2023 |
|
|
|
(Dollars in thousands) |
|
|
(Dollars in thousands) |
|
GAAP Operating Income |
|
$ |
15,897 |
|
|
$ |
36,686 |
|
|
$ |
63,104 |
|
|
$ |
196,244 |
|
|
$ |
203,307 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Transaction-related costs |
|
|
7,144 |
|
|
|
10,409 |
|
|
|
544 |
|
|
|
22,438 |
|
|
|
(57 |
) |
Impairment of long-lived assets |
|
|
13,218 |
|
|
|
— |
|
|
|
— |
|
|
|
13,218 |
|
|
|
— |
|
Purchased intangible amortization |
|
|
5,501 |
|
|
|
4,143 |
|
|
|
649 |
|
|
|
11,034 |
|
|
|
1,957 |
|
Restructuring costs |
|
|
2,441 |
|
|
|
6,869 |
|
|
|
564 |
|
|
|
9,310 |
|
|
|
5,227 |
|
Stock-based compensation |
|
|
9,618 |
|
|
|
10,920 |
|
|
|
10,556 |
|
|
|
42,457 |
|
|
|
61,798 |
|
Other costs |
|
|
3,514 |
|
|
|
283 |
|
|
|
5,944 |
|
|
|
3,897 |
|
|
|
5,944 |
|
Total Non-GAAP Adjustments |
|
$ |
41,436 |
|
|
$ |
32,624 |
|
|
$ |
18,257 |
|
|
$ |
102,354 |
|
|
$ |
74,869 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-GAAP Operating Income |
|
$ |
57,333 |
|
|
$ |
69,310 |
|
|
$ |
81,361 |
|
|
$ |
298,598 |
|
|
$ |
278,176 |
|
Non-GAAP Operating Margin (% of net sales) |
|
|
23.8 |
% |
|
|
27.2 |
% |
|
|
30.2 |
% |
|
|
28.5 |
% |
|
|
28.6 |
% |
Reconciliation of EBITDA and Adjusted EBITDA |
|
|
Three-Month Period Ended |
|
|
Twelve-Month Period Ended |
|
|
|
March 29, 2024 |
|
|
December 29, 2023 |
|
|
March 31, 2023 |
|
|
March 29, 2024 |
|
|
March 31, 2023 |
|
|
|
(Dollars in thousands) |
|
|
(Dollars in thousands) |
|
GAAP Net (Loss) Income |
|
$ |
(7,074 |
) |
|
$ |
33,402 |
|
|
$ |
62,012 |
|
|
$ |
152,888 |
|
|
$ |
187,494 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense |
|
|
5,382 |
|
|
|
3,854 |
|
|
|
755 |
|
|
|
10,763 |
|
|
|
2,336 |
|
Interest income |
|
|
(594 |
) |
|
|
(857 |
) |
|
|
(580 |
) |
|
|
(3,144 |
) |
|
|
(1,724 |
) |
Income tax provision |
|
|
24,325 |
|
|
|
2,969 |
|
|
|
5,909 |
|
|
|
41,909 |
|
|
|
23,852 |
|
Depreciation & amortization |
|
|
21,737 |
|
|
|
20,227 |
|
|
|
14,103 |
|
|
|
71,382 |
|
|
|
50,808 |
|
EBITDA |
|
$ |
43,776 |
|
|
$ |
59,595 |
|
|
$ |
82,199 |
|
|
$ |
273,798 |
|
|
$ |
262,766 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Transaction-related costs |
|
|
7,144 |
|
|
|
10,409 |
|
|
|
544 |
|
|
|
22,438 |
|
|
|
(57 |
) |
Impairment of long-lived assets |
|
|
13,218 |
|
|
|
— |
|
|
|
— |
|
|
|
13,218 |
|
|
|
— |
|
Restructuring costs |
|
|
2,441 |
|
|
|
6,869 |
|
|
|
564 |
|
|
|
9,310 |
|
|
|
5,227 |
|
Stock-based compensation |
|
|
9,618 |
|
|
|
10,920 |
|
|
|
10,556 |
|
|
|
42,457 |
|
|
|
61,798 |
|
Other costs |
|
|
(2,319 |
) |
|
|
(551 |
) |
|
|
786 |
|
|
|
3,020 |
|
|
|
(1,816 |
) |
Adjusted EBITDA |
|
$ |
73,878 |
|
|
$ |
87,242 |
|
|
$ |
94,649 |
|
|
$ |
364,241 |
|
|
$ |
327,918 |
|
Adjusted EBITDA Margin (% of net sales) |
|
|
30.7 |
% |
|
|
34.2 |
% |
|
|
35.1 |
% |
|
|
34.7 |
% |
|
|
33.7 |
% |
Reconciliation of Non-GAAP Profit before Tax |
|
|
Three-Month Period Ended |
|
|
Twelve-Month Period Ended |
|
|
|
March 29,2024 |
|
|
December 29,2023 |
|
|
March 31,2023 |
|
|
March 29,2024 |
|
|
March 31,2023 |
|
|
|
(Dollars in thousands) |
|
|
(Dollars in thousands) |
|
GAAP Income before Income Taxes |
|
$ |
17,251 |
|
|
$ |
36,371 |
|
|
$ |
67,921 |
|
|
$ |
194,797 |
|
|
$ |
211,346 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Transaction-related costs |
|
|
7,144 |
|
|
|
10,409 |
|
|
|
544 |
|
|
|
22,438 |
|
|
|
(57 |
) |
Transaction-related interest |
|
|
163 |
|
|
|
162 |
|
|
|
— |
|
|
|
325 |
|
|
|
— |
|
Impairment of long-lived assets |
|
|
13,218 |
|
|
|
— |
|
|
|
— |
|
|
|
13,218 |
|
|
|
— |
|
Purchased intangible amortization |
|
|
5,501 |
|
|
|
4,143 |
|
|
|
649 |
|
|
|
11,034 |
|
|
|
1,957 |
|
Restructuring costs |
|
|
2,441 |
|
|
|
6,869 |
|
|
|
564 |
|
|
|
9,310 |
|
|
|
5,227 |
|
Stock-based compensation |
|
|
9,618 |
|
|
|
10,920 |
|
|
|
10,556 |
|
|
|
42,457 |
|
|
|
61,798 |
|
Other costs |
|
|
(2,319 |
) |
|
|
(551 |
) |
|
|
786 |
|
|
|
3,020 |
|
|
|
(1,816 |
) |
Total Non-GAAP Adjustments |
|
$ |
35,766 |
|
|
$ |
31,952 |
|
|
$ |
13,099 |
|
|
$ |
101,802 |
|
|
$ |
67,109 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-GAAP Profit before Tax |
|
$ |
53,017 |
|
|
$ |
68,323 |
|
|
$ |
81,020 |
|
|
$ |
296,599 |
|
|
$ |
278,455 |
|
Reconciliation of Non-GAAP Income Tax
Provision |
|
|
Three-Month Period Ended |
|
|
Twelve-Month Period Ended |
|
|
|
March 29,2024 |
|
|
December 29,2023 |
|
|
March 31,2023 |
|
|
March 29,2024 |
|
|
March 31,2023 |
|
|
|
(Dollars in thousands) |
|
|
(Dollars in thousands) |
|
GAAP Income Tax Provision |
|
$ |
24,325 |
|
|
$ |
2,969 |
|
|
$ |
5,909 |
|
|
$ |
41,909 |
|
|
$ |
23,852 |
|
GAAP effective tax rate |
|
|
141.0 |
% |
|
|
8.2 |
% |
|
|
8.7 |
% |
|
|
21.5 |
% |
|
|
11.3 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Tax effect of adjustments to GAAP results |
|
|
(19,263 |
) |
|
|
3,748 |
|
|
|
3,509 |
|
|
|
(9,135 |
) |
|
|
7,285 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-GAAP Income Tax Provision |
|
$ |
5,062 |
|
|
$ |
6,717 |
|
|
$ |
9,418 |
|
|
$ |
32,774 |
|
|
$ |
31,137 |
|
Non-GAAP effective tax rate |
|
|
9.5 |
% |
|
|
9.8 |
% |
|
|
11.6 |
% |
|
|
11.0 |
% |
|
|
11.2 |
% |
Reconciliation of Non-GAAP Net Income |
|
|
Three-Month Period Ended |
|
|
Twelve-Month Period Ended |
|
|
|
March 29,2024 |
|
|
December 29,2023 |
|
|
March 31,2023 |
|
|
March 29,2024 |
|
|
March 31,2023 |
|
|
|
(Dollars in thousands) |
|
|
(Dollars in thousands) |
|
GAAP Net (Loss) Income Attributable to Allegro
MicroSystems, Inc. |
|
$ |
(7,115 |
) |
|
$ |
33,345 |
|
|
$ |
61,977 |
|
|
$ |
152,697 |
|
|
$ |
187,357 |
|
GAAP Basic Earnings per Share |
|
$ |
(0.04 |
) |
|
$ |
0.17 |
|
|
$ |
0.32 |
|
|
$ |
0.79 |
|
|
$ |
0.98 |
|
GAAP Diluted Earnings per Share |
|
$ |
(0.04 |
) |
|
$ |
0.17 |
|
|
$ |
0.32 |
|
|
$ |
0.78 |
|
|
$ |
0.97 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Transaction-related costs |
|
|
7,144 |
|
|
|
10,409 |
|
|
|
544 |
|
|
|
22,438 |
|
|
|
(57 |
) |
Transaction-related interest |
|
|
163 |
|
|
|
162 |
|
|
|
— |
|
|
|
325 |
|
|
|
— |
|
Impairment of long-lived assets |
|
|
13,218 |
|
|
|
— |
|
|
|
— |
|
|
|
13,218 |
|
|
|
— |
|
Purchased intangible amortization |
|
|
5,501 |
|
|
|
4,143 |
|
|
|
649 |
|
|
|
11,034 |
|
|
|
1,957 |
|
Restructuring costs |
|
|
2,441 |
|
|
|
6,869 |
|
|
|
564 |
|
|
|
9,310 |
|
|
|
5,227 |
|
Stock-based compensation |
|
|
9,618 |
|
|
|
10,920 |
|
|
|
10,556 |
|
|
|
42,457 |
|
|
|
61,798 |
|
Other costs |
|
|
(2,319 |
) |
|
|
(551 |
) |
|
|
786 |
|
|
|
3,020 |
|
|
|
(1,816 |
) |
Total Non-GAAP Adjustments |
|
|
35,766 |
|
|
|
31,952 |
|
|
|
13,099 |
|
|
|
101,802 |
|
|
|
67,109 |
|
Tax effect of adjustments to GAAP results |
|
$ |
19,263 |
|
|
$ |
(3,748 |
) |
|
$ |
(3,509 |
) |
|
$ |
9,135 |
|
|
$ |
(7,285 |
) |
Non-GAAP Net Income Attributable to Allegro MicroSystems,
Inc. |
|
$ |
47,914 |
|
|
$ |
61,549 |
|
|
$ |
71,567 |
|
|
$ |
263,634 |
|
|
$ |
247,181 |
|
Basic weighted average common shares |
|
|
193,139,519 |
|
|
|
192,724,541 |
|
|
|
191,519,850 |
|
|
|
192,573,169 |
|
|
|
191,197,452 |
|
Diluted weighted average common shares |
|
|
194,487,307 |
|
|
|
194,570,380 |
|
|
|
194,993,241 |
|
|
|
194,674,352 |
|
|
|
193,688,102 |
|
Non-GAAP Basic Earnings per Share |
|
$ |
0.25 |
|
|
$ |
0.32 |
|
|
$ |
0.37 |
|
|
$ |
1.37 |
|
|
$ |
1.29 |
|
Non-GAAP Diluted Earnings per Share |
|
$ |
0.25 |
|
|
$ |
0.32 |
|
|
$ |
0.37 |
|
|
$ |
1.35 |
|
|
$ |
1.28 |
|
Reconciliation of Non-GAAP Free Cash Flow |
|
|
Three-Month Period Ended |
|
|
Twelve-Month Period Ended |
|
|
|
March 29,2024 |
|
|
March 31,2023 |
|
|
March 29,2024 |
|
|
March 31,2023 |
|
|
|
(Dollars in thousands) |
|
|
(Dollars in thousands) |
|
GAAP Operating Cash Flow |
|
$ |
12,764 |
|
|
$ |
47,548 |
|
|
$ |
181,715 |
|
|
$ |
193,206 |
|
Non-GAAP adjustments |
|
|
|
|
|
|
|
|
|
|
|
|
Purchases of property, plant and equipment |
|
|
(14,272 |
) |
|
|
(30,212 |
) |
|
|
(124,772 |
) |
|
|
(79,775 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-GAAP Free Cash Flow |
|
$ |
(1,508 |
) |
|
$ |
17,336 |
|
|
$ |
56,943 |
|
|
$ |
113,431 |
|
Non-GAAP Free Cash Flow % of net sales |
|
|
(0.6 |
)% |
|
|
6.4 |
% |
|
|
5.4 |
% |
|
|
11.7 |
% |
Investor Contact: Jalene Hoover
VP of Investor Relations & Corporate Communications +1 (512)
751-6526 jhoover@allegromicro.com
Allegro MicroSystems (NASDAQ:ALGM)
Historical Stock Chart
From May 2024 to Jun 2024
Allegro MicroSystems (NASDAQ:ALGM)
Historical Stock Chart
From Jun 2023 to Jun 2024